Agriculture
February 14, 2024
EasyNat TB-CPA Diagnostic Kit
Read SolutionImplemented by
USTAR Biotechnologies (Hangzhou) LTD
Updated on February 26, 2024
·Created on October 21, 2021
Gazelle diagnostic device is a non-invasive sickle cell and malaria diagnostic device
Gazelle is a compact, rugged, and portable battery-operated point-of-care test diagnostic device for anemia and sickle cell disease (SCD) with results in just minutes. There are two variants of the device, the Gazelle Hb Variant and the Gazelle malaria. A commercialized tool for anemia is being developed with the goal of a one-minute 25-cent noninvasive diagnostic tool for screening anemia, malaria, and SCD using an optical finger sensor.
Target SDGs
SDG 3: Good Health and Well-Being
Market Suggested Retail Price
$1,200.00
Market Suggested Retail Price (Secondary Currency)
1.00
Target Users (Target Impact Group)
Small and Medium-sized Enterprises, Public Sector Agencies
Distributors / Implementing Organizations
The product is distributed by the following institutions: Hemex Health, HemexDx Case Western Reserve University, Novartis Biome,Tata Elxsi, Bio-Rad Laboratories
Competitive Landscape
Direct competitors include HemoCue WBC DIFF System.
Manufacturing/Building Method
The device is manufactured at Robonik India. The cartridges are manufactured at Lakshmi Lifesciences, Coimbatore.
Intellectural Property Type
Patent
User Provision Model
The product can be directly ordered from the manufacturer or other distributors like EHACLINICS
Distributions to Date Status
As of 2021, 300 Gazelle’s devices have been distributed to date. (Interview with representative)
Consumables
Cartridges, Pipette with tips, Eppendorf tubes. Interview with representative
Detection sensitivity
The Gazelle tests outperformed Rapid Diagnostic Test (RDT) for P. Vivax Malaria with sensitivity of 96.2% versus 83.9% for current RDTs as reported in a malaria journal
Indispensable equipment for function (Y/N)
Yes
Maintenance or calibration required by user at time of use? (Y/N)
No
Number of Tests Performed
35 – 40 samples per day
Power supply type: Continuous, Recharging only (V, time required, battery life), Other
Designed with an in-built battery that can be recharged to run the whole day
Time required for procedure (minutes)
8 minutes
Design Specifications
The 3.5 kg portable device operates on the Magneto-Optical Detector (MOD) which works by detecting a byproduct of malaria infection in a drop of blood. When malaria parasites consume red blood cells, they create paramagnetic iron-containing crystals called hemozoin inside red blood cells as shown below. The magneto-optical sensors in the reader measure hemozoin levels. In the case of sickle cell, the reader uses microchip electrophoresis to identify and quantify hemoglobin levels in a blood sample inserted into a cartridge that goes directly into the reader. The device is designed with an in-built battery that can be recharged to run the whole day using an android phone charger. The device can run about 35 to 40 samples a day. Mechanism of hemozoin detection by MOD
Technical Support
The technical support is provided by the manufacturer and distributors like EHACLINICS
Replacement Components
There are no replacement components for the device. The device is not to be serviced in the field. Interview with representative
Lifecycle
5 years Interview with representative
Manufacturer Specified Performance Parameters
The manufacturer has the following specified targets: lightweight, transportable, battery-powered, designed for most extreme environments, designed with no cold chain requirements, cloud-based storage
Vetted Performance Status
Gazelle has a CE Mark and regulatory approval in India and Ghana after its sickle cell disease test with other registrations pending. The Gazelle Malaria test outperformed Rapid Diagnostic Tests (RDTs) in sensitivity tests in detecting Plasmodium vivax (P. vivax) malaria.
Safety
Users are advised to be careful when handling patient blood samples. Interview with representative
Complementary Technical Systems
The Gazelle cloud application stores over 2500 patient reports that can be viewed onscreen or sent to a connected printer. Users can download the reports to a USB drive for transfer to a personal computer.
Academic Research and References
N. Hasan, A. Fraiwan, J. A. Little and U. A. Gurkan, 2017, A low-cost, mass-producible point-of-care platform for diagnosing hemoglobin disorders, 2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT), pp. 164-167
Rajat Kumar et al., 2020, First successful field evaluation of new, one-minute haemozoin-based malaria diagnostic device, EClinicalMedicine, Volume 22, pp. 10034
An, R., et al., 2021, Emerging point-of-care technologies for anemia detection, Lab Chip, 221, pp.1843-1865
Datta, Jyothi, “HemexDx’s one-minute, low-cost test for malaria undergoing regulatory review“, The Hindu Businessline, 2020
The Daily, “A new weapon in the fight against sickle cell disease“, Case Western Reserve University, 2020
TATA ELXSI, “a point-of-care diagnostic platform“, 20178
Hemex Health, “New Research Shows Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Accurate Sickle Cell Disease Detection“, Yahoo! Finance, 2020
Hemex Health, “Gazelle® Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis“, Globe Newswire, 2020
Cheney, Catherine, “Optimized for the underserved: A new diagnostic test built for low-income settings“, Devex, 2020
Sheon David, “Gazelle® Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis“, Case Western Reserve University, 2020
Christian Connections for International Health, “Sickle Cell Disease: New Solutions for Diagnosis and Management“, 2020
Compliance with regulations
Gazelle diagnostic device has regulatory approval in Ghana and India. The product also has a CE mark
Evaluation methods
Sensitivity and specificity testing: A study conducted in the Brazilian Amazon on P. vivax showed that Gazelle was more sensitive than RDTs and comparable in accuracy to expert microscopy, but significantly faster than RDTs, microscopy and PCR as reported by Yahoo! finance
Other Information
The Battery-powered equipment that can run 200 tests independently
Agriculture
February 14, 2024
Implemented by
USTAR Biotechnologies (Hangzhou) LTD
Agriculture
March 11, 2024
Implemented by
OrthoTrauma
Agriculture
February 26, 2024
Implemented by
Wyss Institute
Agriculture
February 21, 2024
Implemented by
Equalize Health
Agriculture
February 8, 2024
Implemented by
Design That Matters (DtM)
Agriculture
November 24, 2023
Implemented by
Hadleigh Health Technologies, and Rice 360
Agriculture
November 22, 2023
Implemented by
The NeoRest team at the Seattle Children’s Hopsital
Agriculture
February 29, 2024
Implemented by
Jian Zhong Shang
Agriculture
December 12, 2023
Implemented by
Sohum Innovation lab
Agriculture
September 26, 2024
Implemented by
Jorge Odón
Have thoughts on how we can improve?
Give Us Feedback